Fredun Pharmaceuticals Complete Financial Statements
FREDUN • Review detailed financials to uncover trends, confirm thesis & journal trades
11 Years of Data
2025 - 2015
Complete Financial Data Export
Export complete financial statements for Fredun Pharmaceuticals (FREDUN).
Downloads include all available records across all periods.
For market performance, see the
FREDUN stock price today
.
Profitability Ratios
Net Profit Margin
6.25%
2025 data
EBITDA Margin
14.58%
2025 data
Operating Margin
14.00%
2025 data
Return on Assets
1.85%
2025 data
Return on Equity
6.38%
2025 data
Balance Sheet Ratios
Current Ratio
23.78
2025 data
Debt to Equity
3.45
2025 data
Equity Ratio
28.95%
2025 data
Asset Turnover
0.30
2025 data
Year-over-Year Growth Analysis
Comparing Sept 2024 vs Sept 2025
Assets Growth
+58.1%
Year-over-Year
Equity Growth
+15.6%
Year-over-Year
Liabilities Growth
+58.1%
Year-over-Year
Operating Cash Flow Growth
+100.0%
Year-over-Year
Investing Cash Flow Growth
+11.1%
Year-over-Year
Financing Cash Flow Growth
-76.0%
Year-over-Year
Income Statement
Periods
₹ Crores
| Particulars | Sept 2025 | Mar 2025 | Jun 2025 | Sept 2024 | Jun 2024 | Dec 2024 |
|---|---|---|---|---|---|---|
| Revenue | 144 | 165 | 119 | 0 | 0 | 286 |
| Expenses | 123 | 150 | 103 | 0 | 0 | 251 |
| EBITDA | 21 | 15 | 17 | 0 | 0 | 35 |
| Operating Profit Margin % | 14.00% | 9.00% | 14.00% | 0.00% | 0.00% | 12.00% |
| Depreciation | 2 | 2 | 1 | 0 | 0 | 3 |
| Interest | 8 | 8 | 7 | 0 | 0 | 14 |
| Profit Before Tax | 13 | 7 | 9 | 0 | 0 | 20 |
| Tax | 3 | 1 | 2 | 0 | 0 | 7 |
| Net Profit | 9 | 6 | 7 | 0 | 0 | 14 |
| Earnings Per Share (₹) | 19.98 | 12.71 | 14.33 | 0.00 | 0.00 | 29.09 |
Related Pages for Fredun Pharmaceuticals
Additional stock information and data for FREDUN
Balance Sheet
Years
Annual Data
₹ Crores
| Particulars | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| ASSETS | |||||||||||
| Total Assets | 487 | 308 | 257 | 187 | 162 | 141 | 105 | 79 | 56 | 43 | 23 |
| Current Assets | 428 | 257 | 216 | 153 | 130 | 109 | 73 | 52 | 35 | 28 | 13 |
| Fixed Assets | 53 | 47 | 39 | 32 | 30 | 31 | 31 | 16 | 16 | 15 | 8 |
| Capital Work in Progress | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 11 | 4 | 0 | 1 |
| Investments | 240 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Assets | 0 | 260 | 218 | 155 | 131 | 110 | 74 | 52 | 36 | 29 | 14 |
| LIABILITIES | |||||||||||
| Total Liabilities | 487 | 308 | 257 | 187 | 162 | 141 | 105 | 79 | 56 | 43 | 23 |
| Current Liabilities | 18 | 19 | 21 | 45 | 32 | 14 | 13 | 14 | 8 | 7 | 4 |
| Non-Current Liabilities | |||||||||||
| SHAREHOLDERS' EQUITY | |||||||||||
| Total Equity | 141 | 122 | 96 | 68 | 43 | 41 | 39 | 22 | 7 | 4 | 3 |
| Share Capital | 5 | 5 | 5 | 4 | 4 | 4 | 4 | 3 | 5 | 3 | 3 |
| Reserves & Surplus | 137 | 115 | 84 | 63 | 39 | 37 | 35 | 19 | 2 | 1 | 1 |
Cash Flow Statement
Periods
₹ Crores
| Particulars | March 2024 | March 2023 | March 2022 | March 2021 | March 2020 | March 2019 | March 2018 | March 2017 | March 2016 | March 2015 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | 0 | -14 | -2 | 0 | -11 | 1 | 17 | 4 | 3 | 2 |
| Investing Activities | -8 | -9 | -4 | -1 | -2 | -5 | -8 | -7 | -6 | -3 |
| Financing Activities | 6 | 25 | 8 | -1 | 14 | 4 | -8 | 3 | 4 | 1 |
| Net Cash Flow | -2 | 1 | 1 | -2 | 2 | 0 | 1 | -1 | 1 | 0 |